Pages that link to "Item:Q1929695"
From MaRDI portal
The following pages link to Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695):
Displaying 6 items.
- Incoherent dose-escalation in phase I trials using the escalation with overdose control approach (Q725696) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages (Q6572291) (← links)
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)